![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.reuters.com/business/healthcare-pharmaceuticals/eu-antitrust-regulators-accept-vifor-pharmas-pledge-not-disparage-rival-2024-07-22/
https://www.fiercepharma.com/manufacturing/german-cdmo-cordenpharma-invests-981m-bolster-glp-1-manufacturing
https://www.reuters.com/sustainability/eu-commission-seeks-feedback-vifors-commitments-rivals-disparagement-case-2024-04-19/
https://www.prnewswire.com/news-releases/vafseo-approved-by-the-us-fda-for-the-treatment-of-anemia-due-to-chronic-kidney-disease-in-dialysis-dependent-adult-patients-302102216.html
https://www.prnewswire.com/news-releases/ferinject-approved-by-health-canada-for-the-treatment-of-iron-deficiency-anemia-in-adult-and-pediatric-patients-and-iron-deficiency-in-adult-patients-with-heart-failure-302092736.html
https://www.reuters.com/business/healthcare-pharmaceuticals/travere-drug-rare-kidney-condition-recommended-eu-approval-2024-02-23/
https://www.fiercepharma.com/pharma/csls-ceo-cites-dampened-sales-expectations-vifor-unit-commercial-and-regulatory-hurdles
https://www.prnewswire.com/news-releases/iron-deficiency-day-2023-csl-vifor-calls-for-access-to-iron-deficiency-diagnosis-and-treatment-301996744.html
https://www.prnewswire.com/news-releases/ferinject-granted-upgraded-recommendations-in-2023-esc-heart-failure-guidelines-301911066.html
https://www.ema.europa.eu/en/documents/overview/tavneos-epar-medicine-overview_en.pdf